EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae

Meilin Wu, Jiayang Li, Zhitao Zhou, Yong Chen, Mingjie Qiu, Liuqing Dou, Li Xu, Xiuwen Wu, Jianan Ren

Journal of Antimicrobial Chemotherapy · 19.01.2026 · 81 (2)

DOI: 10.1093/jac/dkaf504 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 19.01.2026. Verfasst von Meilin Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Tigecycline, Drug Resistance, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Navigation Project of Clinical Research, Jiangsu Funding Program for Excellent Postdoctoral Talent.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella pneumoniae (KP) is a Gram-negative, opportunistic pathogen known for causing hospital/community-acquired infections, with carbapenem-resistant Klebsiella pneumoniae (CRKP) being a major global health threat due to its resistance to last-resort antibiotics. Tigecycline is one of the most commonly used and accessible agents for CRKP treatment. However, the rapid spread of resistance genes via mobile genetic elements has led to an increase in bacterial resistance, thereby undermining the clinical efficacy. Additionally, controversy remains regarding the MIC breakpoint of tigecycline for KP, with either overestimation or underestimation of resistance rates, which complicates evaluation and selection of appropriate treatment regimens for clinicians. This review aims to elucidate the mechanisms of tigecycline resistance in KP strains, including the newly discovered mutants or resistance mechanisms mediated by efflux pumps and two-component regulatory systems. Subsequently, a global epidemiology of CRKP isolates with different tigecycline MIC values is conducted, finding that the resistance rates in Asia are higher than that in Europe and America. Furthermore, the latest clinical progresses of tigecycline in terms of dosage, combination regimen and adverse events are analysed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeTigecyclineDrug Resistance, BacterialAnti-Bacterial AgentsGenes, MDRBacterial Outer Membrane ProteinsKlebsiella InfectionsHumans

Substanzen

TigecyclineAnti-Bacterial AgentsBacterial Outer Membrane Proteins

Autor:innen und Institutionen

  • Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210008, China.
  • Research Institute of General Surgery, The Jinling School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu 210008, China.
  • Institute of Laboratory Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing University, Nanjing, Jiangsu 210008, China.
  • Research Institute of General Surgery, Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.

Förderung

  • Navigation Project of Clinical Research
  • Jiangsu Funding Program for Excellent Postdoctoral Talent

Zitieren

APA

Wu, M., Li, J., Zhou, Z., Chen, Y., Qiu, M., Dou, L., Xu, L., Wu, X., & Ren, J. (2026). Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy, 81(2). https://doi.org/10.1093/jac/dkaf504

Vancouver

Wu M, Li J, Zhou Z, Chen Y, Qiu M, Dou L, et al. Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 2026;81(2). doi:10.1093/jac/dkaf504

BibTeX
@article{Wu2026,
  author = {Wu, Meilin and Li, Jiayang and Zhou, Zhitao and Chen, Yong and Qiu, Mingjie and Dou, Liuqing and Xu, Li and Wu, Xiuwen and Ren, Jianan},
  title = {Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {2},
  doi = {10.1093/jac/dkaf504}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche